Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
about
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Prognostic and predictive valu ...... analysis of a phase II study.
@ast
Prognostic and predictive valu ...... analysis of a phase II study.
@en
type
label
Prognostic and predictive valu ...... analysis of a phase II study.
@ast
Prognostic and predictive valu ...... analysis of a phase II study.
@en
prefLabel
Prognostic and predictive valu ...... analysis of a phase II study.
@ast
Prognostic and predictive valu ...... analysis of a phase II study.
@en
P2093
P2860
P1476
Prognostic and predictive valu ...... analysis of a phase II study.
@en
P2093
Carrie Morano
David D'Haese
David R Spigel
Eyas Raddad
John Polzer
John R Stille
Kurt Baeten
Madeline Repollet
Mark C Connelly
P2860
P2888
P304
P356
10.1007/S10637-017-0446-Z
P50
P577
2017-03-15T00:00:00Z
P6179
1084025948